SoufCut ATC -
SoufCut(TM) Autologous Adipose Tissue Collection System
BioGend Therapeutics (6733) has unveiled the SoufCutTM Autologous Adipose Tissue Collection System at the event. This innovative system is capable of harvesting stromal vascular fraction (SVF) cells from adipose tissue, which can be applied in the treatment of challenging wounds, degenerative joint conditions, hair loss, and aesthetics. In contrast to the traditional months-long in vitro cultivation process, this system only requires a single surgical procedure that takes around 1 hour. It allows for the extraction of SVF cells directly in the operating room.
